XBIO
Xenetic Biosciences
$2.12
+$0.02 (+0.95%)Oct 29, 2026
Key metrics
The numbers that frame XBIO today
- Market cap
- $4.97M
- Gross margin
- 100%
- ROIC
- 683.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.58
- 52wk High
- $4.94
Growth
Revenue and earnings trend for XBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about XBIO
Is Xenetic Biosciences a good buy?
No. Xenetic Biosciences has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup.
What is the market capitalization of XBIO?
Xenetic Biosciences's market capitalization is $4.97M.
What is the 52-week high for XBIO stock?
The 52-week high for Xenetic Biosciences is $4.94. The current close of $2.12 is 57.1% below that high.
What is the 52-week low for XBIO stock?
The 52-week low for Xenetic Biosciences is $1.58. The current close of $2.12 is 34.2% above that low.
Does XBIO stock pay dividends?
Xenetic Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XBIO?
Xenetic Biosciences's Debt / Equity ratio is 0.